By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Auris Medical AG 

Aeschenvorstadt 37

Basel    4051  Switzerland
Phone: 41-61-201-13-50 Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares 7/21/2014 7:36:05 AM
Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus 3/31/2014 9:01:12 AM
Auris Medical AG Announces Enrollment Of First Patient In North American Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 3/10/2014 9:12:37 AM
Auris Medical AG Announces Enrollment Of First Patient In European Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 2/21/2014 8:55:18 AM
Auris Medical AG Reaches Special Protocol Assessment Agreement With FDA for Pivotal Phase III Clinical Trial With AM-101 in Treatment of Acute Peripheral Tinnitus 11/4/2013 9:40:11 AM
Second Phase II Clinical Trial Confirms Safety and Efficacy Trends for Auris Medical AG's AM-101 in Treatment of Acute Peripheral Tinnitus 9/9/2013 9:27:19 AM
Safety Results From Auris Medical AG's Clinical Development of AM-101 Presented at International Conference 5/17/2013 9:25:22 AM
Auris Medical AG Secures $50.6 Million Series C Financing 4/16/2013 6:39:06 AM
Auris Medical AG Completes Enrolment in TACTT1 Study With AM-101 for the Treatment of Acute Peripheral Tinnitus 2/13/2013 2:35:17 PM
Auris Medical AG Reporting Positive Results From Phase IIb Trial With AM-111 for the Treatment of Acute Sensorineural Hearing Loss 11/13/2012 11:34:35 AM
1234
//-->